2-<2-Hydroxyethylthio>pyrimidin | 20957-33-9

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 2-<2-Hydroxyethylthio>pyrimidin
• 英文别名: 2-(2-Hydroxyethylthio)-pyrimidin；2-pyrimidin-2-ylsulfanyl-ethanol；Ethanol, 2-(2-pyrimidinylthio)-；2-pyrimidin-2-ylsulfanylethanol
• CAS: 20957-33-9
• 化学式: C₆H₈N₂OS
• mdl: MFCD12169605
• 分子量: 156.208
• InChiKey: ARHFPHXFTXGVGL-UHFFFAOYSA-N

物化性质

• 沸点：
  304.1±25.0 °C(Predicted)
• 密度：
  1.29±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  71.3
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0620003A1

  公开（公告）日：1994-10-19

  A benzazepine compound represented by formulae (I) or (II) or a salt thereof, and a vasopressin antagonist or an oxytocin antagonist containing the above compound as the active ingredient.

  由式（I）或（II）代表的苯并氮杂卓化合物或其盐，以及含有上述化合物作为活性成分的血管加压素拮抗剂或催产素拮抗剂。
• Vasopressin antagonist and oxytocin antagonist
  申请人：Otsuka Pharmaceutical Company, Limited

  公开号：EP1902717A2

  公开（公告）日：2008-03-26

  An object of the present invention is to provide a vasopressin antagonist and oxytocin antagonist. The vasopressing antagonist and oxytocin antagonist according to the present invention contain, as the active ingredient, a benzoheterocyclic compound represented by the general formula (1): (wherein R1, R2, R3, R4, R5 and the carbon-carbon bond between 4- and 5-positions in the benzoazepine skeleton are the same as defined in Claims 1 and 2) or salt thereof.

  本发明的目的是提供一种血管加压素拮抗剂和催产素拮抗剂。 根据本发明，血管加压素拮抗剂和催产素拮抗剂含有通式（1）所代表的苯并杂环化合物作为活性成分： (其中 R1、R2、R3、R4、R5 和苯并氮杂卓骨架中 4 位和 5 位之间的碳-碳键与权利要求 1 和 2 中定义的相同）或其盐。
• US5622947A
  申请人：——

  公开号：US5622947A

  公开（公告）日：1997-04-22
• US5753644A
  申请人：——

  公开号：US5753644A

  公开（公告）日：1998-05-19
• [EN] COMPOSITION FOR TIN-SILVER ALLOY ELECTROPLATING COMPRISING A COMPLEXING AGENT<br/>[FR] COMPOSITION POUR L'ÉLECTROGALVANISATION D'ALLIAGE D'ÉTAIN ET D'ARGENT COMPRENANT UN AGENT COMPLEXANT
  申请人：BASF SE

  公开号：WO2021052817A1

  公开（公告）日：2021-03-25

  An aqueous composition comprising (a) metal ions comprising or consisting of tin ions and silver ions and (b) at least one complexing agent of formula (C11): RC12-XC11-RC11 and their salts, wherein XC11 is selected from (a) a divalent 5 or 6 membered aromatic N-heterocyclic group comprising (i) a single N atom; or (ii) a first N atom and a second heteroatom selected from N and S, wherein the first N atom and the second heteroatom are separated by at least one C atom; or (iii) a triazole or thiadiazole; (b) a divalent 6 membered aromatic carbocyclic group; (c) a divalent 5 or 6 membered aliphatic N-heterocyclic group comprising one N atom and optionally a second heteroatom selected from N and O; all of which may be unsubstituted or substituted by one or more OH or one or more RC14; RC11 is selected from (a) -XC12-S [-XC13-DC11]n-RC13, (b), and (c); RC12 is selected from RC11, XC11-RC11, H, OH, NRC14 2, C1 to C10 alkyl, and C1 to C10 alkoxy; XC12 is a chemical bond or a linear, branched or cyclic C1-C6 alkanediyl, which may be unsubstituted or substituted by OH, with the proviso that if XC11 is (a) a divalent 5 or 6 membered aromatic N-heterocyclic group and (b) RC13 is substituted by one OH and (c) RC12 is not RC11, then XC12 is a chemical bond; XC13 is a linear, branched or cyclic C1-C6 alkanediyl, which may be unsubstituted or substituted by OH; XC14 is a chemical bond or a linear or branched C1-C4 alkanediyl; DC11 is selected from S and O; RC13 is selected from (a) a linear, branched or cyclic C1-C6 alkyl, which may be unsubstituted or substituted by one or more OH, (b) if XC11 is not an aromatic carbocyclic group, Ph, XC14- Ph, with Ph=phenyl, and (c) a C2 to C4 polyoxyalkylene group; with the proviso that if XC11 is a divalent 5 or 6 membered aromatic N-heterocyclic group, then RC13 is unsubstituted or substituted by one OH with the exception that if XC11 is a divalent 5 or 6 membered aromatic N-heterocyclic group comprising a first N atom and a second heteroatom selected from N, then RC13 is unsubstituted. RC14 is selected from H and a linear, branched or cyclic C1-C6 alkyl; n is 0 or an integer of from 1 to 5.